Literature DB >> 18388496

Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters.

Joost J van Veen1, Alex Gatt, Peter C Cooper, Steven Kitchen, Annette E Bowyer, Mike Makris.   

Abstract

The fluorogenic calibrated automated thrombin-generation assay is influenced by contact pathway activation in platelet-rich and platelet-poor plasma. This influence lessens with increasing tissue factor (TF) concentrations and is inhibited by corn trypsin inhibitor (CTI). CTI is expensive and at what TF concentration its influence becomes irrelevant is unclear. Spiking of factor VIII (FVIII)-depleted plasma with FVIII, in samples without CTI, shows a plateau of thrombin generation at low normal FVIII levels. Given the association with thrombosis at high levels, a continuing increase in thrombin generation would be expected. We studied the effect of CTI on this relation by spiking experiments up to 4.8 IU/ml at 1 pmol/l TF and compared the influence of CTI at 1 and 5 pmol/l in platelet-poor plasma. CTI significantly influences thrombin generation in platelet-poor plasma at 1 pmol/l TF (difference of means for endogenous thrombin potential of 232.5 nmol/l per min, P<0.0001) and peak of 48 nmol/l (P<0.0001)) but not at 5 pmol/l. Spiking experiments without CTI confirm the hyperbolic relation between FVIII coagulant activity (FVIII:C) and endogenous thrombin potential with a plateau at 0.70-1.40 IU/ml. With CTI, a near-linear response up to 1.0 IU/ml was found with a plateau at 2.4-4.8 IU/ml. For peak thrombin, no plateau was reached with CTI. The present study confirms and extends previous data on CTI and the relationship between FVIII:C and thrombin generation. CTI is not necessary at 5 pmol/l TF, and thrombin generation remains dependent on FVIII:C up to 4.8 IU/ml at 1 pmol/l with CTI. Higher levels than previously thought may be needed to normalize thrombin generation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388496     DOI: 10.1097/MBC.0b013e3282f4bb47

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  20 in total

1.  The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: comment.

Authors:  S Butenas; K G Mann
Journal:  J Thromb Haemost       Date:  2015-01-14       Impact factor: 5.824

2.  Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH.

Authors:  Y Dargaud; A S Wolberg; E Gray; C Negrier; H C Hemker
Journal:  J Thromb Haemost       Date:  2017-06-28       Impact factor: 5.824

3.  Crosslinking decreases the hemocompatibility of decellularized, porcine small intestinal submucosa.

Authors:  Jeremy J Glynn; Elizabeth G Polsin; Monica T Hinds
Journal:  Acta Biomater       Date:  2014-11-25       Impact factor: 8.947

4.  Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?

Authors:  Brian Dale; John W Eikelboom; Jeffrey I Weitz; Ed Young; Jeremy S Paikin; Michiel Coppens; Richard P Whitlock; Stuart J Connolly; Jeffrey S Ginsberg; Jack Hirsh
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

5.  Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood.

Authors:  Manash S Chatterjee; William S Denney; Huiyan Jing; Scott L Diamond
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

6.  A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.

Authors:  Tomoko Matsumoto; Keiji Nogami; Kenichi Ogiwara; Midori Shima
Journal:  Int J Hematol       Date:  2009-11-25       Impact factor: 2.490

7.  Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy.

Authors:  Joost J van Veen; Kingsley K Hampton; Rhona Maclean; Fiona Fairlie; Michael Makris
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

8.  Specific and global coagulation assays in the diagnosis of discrepant mild hemophilia A.

Authors:  Annette E Bowyer; Joost J Van Veen; Anne C Goodeve; Steve Kitchen; Michael Makris
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

9.  Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay.

Authors:  Veronique Ollivier; Jianguo Wang; David Manly; Kellie R Machlus; Alisa S Wolberg; Martine Jandrot-Perrus; Nigel Mackman
Journal:  Thromb Res       Date:  2009-04-05       Impact factor: 3.944

10.  Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma.

Authors:  Kevin Z Xin; William C Chang; Mikhail V Ovanesov
Journal:  Thromb Res       Date:  2015-11-19       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.